review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Felipe Kenji Sudo | Q82282235 |
Fernanda De Felice | Q87769550 | ||
P2093 | author name string | Paulo Mattos | |
Claudia Drummond | |||
Naima Assuncao | |||
P2860 | cites work | Contribution of metabolic syndrome components to cognition in older individuals. | Q51902591 |
Metabolic syndrome and cognitive function: a population-based follow-up study in elderly women. | Q51910895 | ||
Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. | Q53948635 | ||
Metabolic Syndrome: prevalence and prediction of mortality in elderly individuals | Q56996919 | ||
An Adequate Threshold for Body Mass Index to Detect Underweight Condition in Elderly Persons: The Italian Longitudinal Study on Aging (ILSA) | Q60441352 | ||
The relationship between body mass index and waist circumference: implications for estimates of the population prevalence of overweight | Q74200426 | ||
Metabolic syndrome--definition and diagnostic criteria in Japan | Q82179327 | ||
The metabolic syndrome, inflammation, and risk of cognitive decline | Q45145786 | ||
Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study | Q46223560 | ||
Association of metabolic syndrome with cognitive function: the role of sex and age. | Q46420290 | ||
Cognitive assessment in an elderly population with metabolic syndrome in Brazil. | Q47094631 | ||
Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline. | Q47703267 | ||
Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample | Q48315775 | ||
Cognitive impairment and frontal-subcortical geriatric syndrome are associated with metabolic syndrome in a stroke-free population. | Q48424996 | ||
Late-life metabolic syndrome prevents cognitive decline among older men aged 75 years and over: one-year prospective cohort study | Q48466562 | ||
A study on cognitive decline with respect to metabolic syndrome and inflammation in elderly Indians. | Q50575923 | ||
Association between metabolic syndrome and mild cognitive impairment and its age difference in a Chinese community elderly population. | Q50599148 | ||
Nutritional predictors of cognitive impairment severity in demented elderly patients: the key role of BMI. | Q50754905 | ||
Metabolic syndrome is associated with poor memory and executive performance in elderly community residents: the PROOF study. | Q50860432 | ||
Metabolic syndrome and cognitive decline in French elders: the Three-City Study. | Q51021196 | ||
The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. | Q51106364 | ||
Relationship between the diagnostic components of metabolic syndrome (MS) and cognition by ApoE genotype in the elderly. | Q51798865 | ||
Updated national and international hypertension guidelines: a review of current recommendations | Q26824589 | ||
Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease | Q27021770 | ||
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report | Q27861020 | ||
Banting lecture 1988. Role of insulin resistance in human disease | Q29547283 | ||
Metabolic syndrome in the elderly: an overview of the evidence | Q33421460 | ||
The need for harmonisation and innovation of neuropsychological assessment in neurodegenerative dementias in Europe: consensus document of the Joint Program for Neurodegenerative Diseases Working Group | Q33568361 | ||
The Modified Mini-Mental State (3MS) examination | Q34185551 | ||
Vascular dementia: a radical redefinition. | Q34333954 | ||
Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation | Q34567335 | ||
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). | Q34636529 | ||
The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension | Q34661652 | ||
Observational studies: getting clear about transparency | Q35232105 | ||
Cardiovascular Disease Risk Factors and Cognition in the Elderly | Q35631257 | ||
Metabolic syndrome and cognitive decline among the oldest old in Okinawa: in search of a mechanism. The KOCOA Project | Q35681285 | ||
Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis. | Q35790090 | ||
Body Mass Index and Decline of Cognitive Function | Q35920955 | ||
Improving clinical cognitive testing: report of the AAN Behavioral Neurology Section Workgroup | Q36027894 | ||
Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes | Q36159157 | ||
The enigma of vascular cognitive disorder and vascular dementia | Q36730292 | ||
The Association Between Obstructive Sleep Apnea and Alzheimer's Disease: A Meta-Analysis Perspective | Q36789078 | ||
Metabolic syndrome and cognitive decline in early Alzheimer's disease and healthy older adults | Q36880464 | ||
Increased risk of cognitive impairment in patients with components of metabolic syndrome | Q37257005 | ||
Early-onset dementias: diagnostic and etiological considerations | Q37606162 | ||
Lifestyle change and the prevention of cognitive decline and dementia: what is the evidence? | Q38089526 | ||
Metabolic syndrome and longitudinal changes in cognitive function: a systematic review and meta-analysis | Q38191801 | ||
Stress, PTSD, and dementia | Q38219874 | ||
Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults: The ALLHAT-LLT Randomized Clinical Trial. | Q38376542 | ||
Smoking history is associated to cognitive impairment in Parkinson's disease | Q38958979 | ||
The metabolic syndrome and 10-year cognitive and functional decline in very old men. A population-based study. | Q39026732 | ||
Executive dysfunction assessed by Clock-Drawing Test in older non-demented subjects with metabolic syndrome is not mediated by white matter lesions. | Q39028258 | ||
Age of onset of hypertension and risk of dementia in the oldest-old: The 90+ Study | Q40370973 | ||
Metabolic syndrome correlates poorly with cognitive performance in stroke-free community-dwelling older adults: a population-based, cross-sectional study in rural Ecuador | Q40768973 | ||
The Metabolic Syndrome Predicts Longitudinal Changes in Clock Drawing Test Performance in Older Nondemented Hypertensive Individuals | Q40955159 | ||
Is there an association between metabolic syndrome and cognitive function in very old adults? The Newcastle 85+ Study | Q41104685 | ||
Cognitive and affective functions in Alzheimer's disease patients with metabolic syndrome | Q41193132 | ||
Metabolic syndrome and cerebrovascular impairment in Alzheimer's disease | Q41261140 | ||
Screening cognition in the elderly with metabolic syndrome. | Q43419162 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | metabolic syndrome | Q657193 |
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | e0194990 | |
P577 | publication date | 2018-03-26 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Metabolic Syndrome and cognitive decline in the elderly: A systematic review | |
P478 | volume | 13 |
Q64087499 | Additional Impact of Glucose Tolerance on Telomere Length in Persons With and Without Metabolic Syndrome in the Elderly Ukraine Population |
Q89960800 | Association between Cognitive Function and Clustered Cardiovascular Risk of Metabolic Syndrome in Older Adults at Risk of Cognitive Decline |
Q64119280 | Associations of the metabolic syndrome and its components with cognitive impairment in older adults |
Q92447867 | Changes in Metabolic Syndrome Status and Risk of Dementia |
Q64228387 | Frailty as a Predictor of Cognitive Disorders: A Systematic Review and Meta-Analysis |
Q59798515 | Frequency of metabolic syndrome and associated factors in institutionalized elderly individuals |
Q98209208 | GUT DYSBIOSIS AND AGE-RELATED NEUROLOGICAL DISEASES; AN INNOVATIVE APPROACH FOR THERAPEUTIC INTERVENTIONS |
Q90552231 | Metabolic risk affects fluid intelligence changes in healthy adults |
Q64100161 | Metabolic syndrome alters relationships between cardiometabolic variables, cognition and white matter hyperintensity load |
Q58103524 | Risk of dementia associated with cardiometabolic abnormalities and depressive symptoms: A longitudinal cohort study using the English Longitudinal Study of Ageing |
Q90918718 | Self-reported sleep disturbances are associated with poorer cognitive performance in older adults with hypertension: a multi-parameter risk factor investigation |
Search more.